Posts Tagged ‘alzheimers’

Ron Martin (genetics and nutrition) and Babry Orem (radiation-plant based nutraceutical) next guests

Monday, May 20th, 2019

OLYMPUS DIGITAL CAMERA

Ron Martin received his BS and MS degrees in Food Science and Nutrition from Chapman University, in Orange, California.  He worked for more than 35 years in the nutraceutical and food industries, including Hunt-Wesson/ConAgra, Plus Products, the William. T. Thompson Co., and the Nutrilite division of Alticor, where he served as Senior Research Scientist in Nutrilite’s New Concepts group.  Ron has been a Professional member of the Institute of Food Technologists (IFT) and is President of Nutrigenetics Unlimited, Inc., which he founded in 2007 (www.Nutrigenetics.net). He is also one of the founding members of the International Society of Nutrigenetics/Nutrigenomics (ISNN, www.NutritionAndGenetics.org).

 

Founder and CEO of Folium Px, Babry Oren was born in the former Soviet Republic of Georgia in 1949. Since 1982, Mr. Oren has owned and operated BAO Corporation in Beverly Hills, California that manufactures and distributes Folium Px , and also serving as its chief executive officer. From 1982 to 1988, that company dealt primarily in oil and gas land acquisition, exploration, drilling, and domestic development. Since its inception, its operational and financial aspects have been managed by Babry Oren.  From 1988 to today, Mr. Oren has continued to serve BAO Corporation as CEO, participating in the same business of acquiring domestic and international land for gas and oil contracts. The role of that company and its president would soon change, however: in 1991, he was appointed as a representative of commercial affairs for the Republic of Georgia in the western United States. In 2001, Mr. Oren was appointed as the Representative of the Peace Fund of Georgia, a non-profit organization, in the United States. His company also expanded its services to include wireless telecommunications and internet to the Russian Federations. Mr. Oren is the founder of an ongoing  telecommunications and Internet businesses in one of Russia’s largest cities. Mr. Oren graduated from in the former Soviet Union with a Master’s degree in Economics/Specification in Industrial Planning.  Three years later, he completed schooling at the Export Institute of Israel in Tel Aviv. Mr. Oren is fluent in over six languages and has traveled extensively throughout the noted regions. Folium Px, which Mr Orem will speak about is a plant based nutraceutical that was developed in Georgia in the former Soviet Union and has the purpose of cleansing free radicals by inactivating them to improve the health of people previously exposed to radiation.  https://foliumpx.com/our-board-of-directors/

Enjoy the Interview Below:

 

 

 

Christian Wilde an Author/Researcher Focuses on Tumeric/Disease Research

Sunday, March 17th, 2019

My guest this week was Christian Wilde an author/researcher who has appeared as a favorite guest on hundreds of radio shows and has been a medical ‘go to’ commentator over 106 times on George Noory’s number 1 international radio show airing to millions of nightly listeners in the US and Canada, Armed Forces Radio, Sirius and computers worldwide. as 95 other nationally syndicated radio shows.

He has authored two landmark books, Hidden Causes of Heart Attack and Stroke and Miracle Stem Cell heart Repair. He also authors the Christian Wilde Stem Cell and Turmeric Research Report covering more than 87 catastrophic diseases.

The author’s work has been supported by the Directors of stem cell research, cardiovascular disease and regenerative medicine at 11 major universities, including Columbia, University of Utah, Minnesota and UCSD. He has been a voice for adult stem cell research, documenting the progress since 2002.

Before his endeavors into the medical arena, Christian was an independent song writer and record producer for Warner Bros. Columbia, Capitol/EMI, United Artists and MCA/UNI records. His current 14 song CD as a singer/songwriter is Journey On Hold.

He recently received the “Excellence in New Health Product Innovation” Award in Cambridge, Maryland at the Emord & Associates 10th year Gala as well as an award “For Inventing Novel and Effective Products that Enhance Health and Life.”

More information on his website  https://www.myheartbook.com/pages/christians-bio    

Enjoy the Interview Below:

 

 

Longevity/Fasting/Stem Cells and Dr Valter Longo, the Guru of Longevity

Sunday, July 15th, 2018

Professor Valter Longo is internationally recognized as a leader in the field of ageing studies and related diseases. His discoveries include some of the major genetic pathways that regulate aging and life-threatening diseases and the identification of a genetic mutation that protects men from several common diseases.

He is a Professor of Gerontology and Biological Science and Director of the Longevity Institution at the School of Gerontology at the University of Southern California in Los Angeles, one of the leading centers devoted to teaching and research on ageing. He is also director of the Oncology Laboratory and longevity at the Institute of Molecular Oncology IFOM in Milan.

Professor Longo received the Nathan Shock Lecture Award from the National Institute on Ageing (NIA/NIH) in 2010 and in 2013 the Vincent Cristofalo ‘Rising Star’ Award for Research on Ageing, and the 2016 Glenn Award for research in the Biology of Aging.

In 2015, after a number of his papers were among the most widely cited in the biomedical field, Time magazine called him a ‘guru of longevity’.

Doctor Longo received a PhD from North Texas in 1992, and another one from UCLA in 1997 and completed post doctoral training in 2000. He has carried out research in the areas of fasting and longevity, cell biology and genetics, the regulation of aging and multiple  stress resistance systems in yeast and mammals, cancer, diabetes and Alzheimer’s.  He has over 70 peer reviewed articles, 4 books/chapters, multiple research grants, active grant reviewer, and student research advisor. He is author of the best seller The Longevity Diet: Discover the New Science Behind Stem Cell Activation and Regeneration to Slow Aging, Fight Disease, and Optimize Weight

More information is available at:                                                                              http://gero.usc.edu/cv2013/CV-LongoV2013.pdf

www.CreateCures.org

Enjoy the Interview Below:

 

Alzheimers-Here today. Gone tomorrow. Good News.

Sunday, November 19th, 2017

 

 

 

 

 

 

Dr. Dale Bredesen is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer’s disease. He graduated from Caltech, then earned his MD from Duke University Medical Center in Durham, NC. He served as Chief Resident in Neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding President and CEO.  Dr Bredesen has mentored many, many physicians and PhD learners in his lab, presented over 300 papers, written over 200 peer reviewed papers written numerous book chapters and abstracts,, written several books including his recent the End of Alzheimer’s: The first program to prevent and reverse cognitive decline, received numerous patents and honors. In addition, recently he has been interviewed on many television  and radio shows including Dr Oz. You can see his curriculum vitae at: https://docs.wixstatic.com/ugd/1a2e49_f0a51bffa9a341dca2ab7af9b6fd0c3d.pdf

The uniform failure of recent drug trials in Alzheimer’s disease has highlighted the critical need for a more accurate understanding of the fundamental nature of Alzheimer’s disease. Dr. Bredesen’s research has led to new insight that explains the erosion of memory seen in Alzheimer’s disease, and has opened the door to a new therapeutic approach. He has found evidence that Alzheimer’s disease stems from an imbalance in nerve cell signaling: in the normal brain, specific signals foster nerve connections and memory making, while balancing signals support memory breaking, allowing irrelevant information to be forgotten. But in Alzheimer’s disease, the balance of these opposing signals is disturbed, nerve connections are suppressed, and memories are lost. This model is contrary to popular dogma that Alzheimer’s is a disease of toxicity, caused by the accumulation of sticky plaques in the brain. Bredesen believes the amyloid beta peptide, the source of the plaques, has a normal function in the brain — promoting signals that allow some of the nerve connections to lapse. Thus the increase in the peptide that occurs in Alzheimer’s disease shifts the memory-making vs. memory-breaking balance in favor of memory loss. This work has led to the identification of several new therapeutic candidates that are currently in pre-clinical trials.

Dr. Bredesen’s novel insights into the fundamental nature of Alzheimer’s disease recently attracted an investment of $3.5 million toward a $10 million goal for initial clinical trials of these new therapeutics. This generous support came from the private venture capitalist Douglas Rosenberg, who is helping to fund the Alzheimer’s Drug Discovery Network, centered at the Buck Institute. The unit is screening drug candidates to find those that can preserve a healthy balance in the signaling pathways that support memory. Dr. Bredesen’s work on nerve cell signaling is also the focus of a collaboration between the Buck Institute and BioMarin Pharmaceuticals, Inc., which is seeking treatments for a rare form of Alzheimer’s disease, early onset Familial Alzheimer’s Disease (eFAD), which may develop in people as young as 30 years of age.

Listen to the Interview below:

 

 

Dementia: Are Some Cases Preventable.

Wednesday, July 26th, 2017

Recent research published in Lancet and reported by the first Lancet Commission on Dementia Prevention and Care stated that managing lifestyle factors such as hearing loss, smoking, hypertension, and depression could prevent one-third of the world’s dementia cases. They also said nonpharmacological interventions such as social contact and exercise for people with dementia are beneficial. Researchers said “There’s been a great deal of focus on developing medicines to prevent dementia, including Alzheimer’s disease.” ” But we can’t lose sight of the real major advances we’ve already made in treating dementia, including preventive approaches.”

Twenty four international experts were brought together to systematically review existing research and provide evidence=based recommendations for treating and preventing dementia. Nine risk factors were identified in early, mid and late life that increase the likelihood of developing dementia. They said by increasing education in early life and addressing hearing loss, hypertension, and obesity dementia could be reduced by up to 20 percent. In late life stopping smoking, treating depression, increasing physical activity, increasing social activities, and managing diabetes could reduce dementia by another 15 percent. Evaluating medications they said “Antipsychotic drugs are commonly used to treat agitation and aggression. but there are substantial concern about these drugs because of an increased risk of death, cardiovascular adverse events and infections, not to mention excessive sedation.”

Western Diet and Alzheimers.

Friday, March 11th, 2016

logo1267406_mdIn a study published online in Nature Scientific Reports researchers studied the connection between the western diet and Alzheimer’s based upon previous research that found that a combination of eating a western diet and inactivity contribute to as many as 25 percent of Alzheimer’s cases. In the study mice that were healthy and mice that modeled some aspect of Alzheimer’s were fed a Western diet consisting of high amounts of animal protein, fat and sugars with low plant=based content and nutrient density for 8 months.  this represented the equivalent of late adolescence to early middle age in humans.

Researchers found that the prolonged consumption of the western diet led to a dramatic increase in immune response activities in the brains of all mice, including those that did not model Alzheimer’s disease. There was increased activity of microglia, which functions as the brains immune cells, and monocytes, circling white blood cells that may cross into the brain in response to immune signaling. Findings also strengthing previous associations of the western diet and the development of peripheral inflammation and also that the immune activity in the brain increases Alzheimer’s disease susceptibility. All mice also had a significant increase of microglia/monocytes that express TREM2, a key immune regulatory protein. TREM2 has been strongly linked with suceptibility to Alzheimer’s disease and other age-related neurodegenerative diseases.  However, this was the first study to show an increase on TREM2 cells in response to prolonged consumption of a western diet.

Can Therapy for Prostate Cancer Increase Risk of Alzheimers

Wednesday, December 9th, 2015

Logos 005A new study published in the Journal of Clinical Oncology concluded  that men taking androgen deprivation therapy (ADT) for prostate cancer were almost twice as likely to be diagnosed with Alzheimer’s later in life than those who did not use the therapy based on the analysis of medical records. In addition, men with the longest duration of using ADT were even more likely to suffer Alzheimer’s. Researchers said this does not prove that ADT increases the risk of Alzheimer’s but point to that possibility and are consistent to other evidence that low levels of testosterone may weaken the brain of aging individuals resistance to Alzheimer’s.  The researchers said “We wanted to contribute to the discussion regarding the relative risk and benefits of ADT. and no one had yet looked at the association between ADT and alzheimer’s disease.” “Based on the results of our study, an increase risk of Alzheimer’s disease is a potential adverse effect of ADT, but further research is needed befre considering changes to clinical practice.”

For this study, the researchers evaluated large sets of medical records from two hospitals on the east and west coasts.  In total, there were about 5 million patients. of whom 16,888 had a diagnoses of prostate cancer and met the other criteria of the study. Of the 16,888 prostate cancer patients about 2,400 had received ADT and had the necessary follow up records. This group was compared with a control group of prostate cancer patients who did not receive ADT that were matched by age and other factors.

Using two different statistical analysis methods, the researchers  showed that the ADT group , xompared to the control group, had significantly more Alzheimer’s diagnoses in later years and showed that the ADT group were about 88 percent more likely to develop Alzheimer’s during the follow up period. Further studies are planned  to determine whether ADT does increase Alzheimer’s risk using data from large cancer registries.

Dr Brant Cortright Talks about Neurogenesis.

Sunday, September 13th, 2015

brantBrant Cortright, Ph.D., is a licensed clinical psychologist who works from a psycho-spiritual perspective. He has practiced depth psychotherapy for 30 years in numerous contexts, from hospitals and mental health centers, to workshops and private practice. For the past two decades he has been in private practice in San Francisco working primarily with individuals and couples.

A teacher of transpersonal psychology, Brant conducts workshops and lectures in Europe, India, and the United States. His book Psychotherapy and Spirit: Theory and Practice in Transpersonal Psychotherapy (SUNY Press) is widely used in the field. He has also authored numerous articles. For the past 20 years he has worked in the field of Integral Psychology, a synthesis of the two major streams of depth psychology – the humanistic-existential and contemporary psychoanalytic – within an integrating east-west framework.

Trained in contemporary psychoanalysis, gestalt therapy, and existential psychotherapy, Brant integrates Western psychology with Sri Aurobindo’s integral yoga and philosophy. A long-time practitioner of meditation and hatha yoga, he also draws from Buddhism, Krishnamurti, and mystical Christianity.

Brant is a Professor of Psychology and Director of the Integral Counseling Psychology program at the California Institute of Integral Studies in San Francisco. He is the past Director of the Spiritual Emergence Network. His forthcoming book, Integral Psychotherapy: The Meeting of East and West will be published by SUNY Press in spring, 2007. More information is available  at http://www.BrantCortright.com and  at http://www.NeurogenesisDiet.com.

 

Interview with Dr David O Carpenter on EMF now Available for Listening.

Sunday, July 5th, 2015

Dr David Carpenter, EMF

Dr David O Carpenter is a public health physician who speaks with me on EMF. Dr. Carpenter is currently Director of the Institute for Health and the Environment at the University at Albany and also Professor of Environmental Health Science at the University of Albany in New York. He has carried out extensive research and has more than 370 peer-reviewed publications, 6 books and 50 reviews and book chapters to his credit. More information about EMF was presented on this site a week ago and can also be found at: http://www.albany.edu/sph/18918.php

Enjoy the Interview below:

 

 

 

Interview with Professor Brian Peskin on Fish Oil and PEO’s now Available for Listening.

Sunday, February 17th, 2013

BpeskinMy guest on Saturday was Professor Brian Peskin who is Founder of Lifestyle Engineering Science and author of 8 books including the Hidden Story of Cancer. More information was presented earlier on this site and can be found at: Http://www.brianPeskin.com